Soumen Tapadar

Title: Soumen Tapadar: Innovator in Genetic Disease Detection and Emergency Services

Introduction

Soumen Tapadar is a notable inventor based in Karnataka, India. He has made significant contributions to the fields of healthcare technology and emergency services. With a total of 9 patents to his name, Tapadar is recognized for his innovative solutions that address critical health issues.

Latest Patents

One of his latest patents is focused on an "Indicator for probable inheritance of genetic disease." This invention provides systems, methods, and computer-readable media for identifying patients or family members who may have a genetic disease or are at risk of inheriting one. The process involves identifying the patient's relatives during or after registration. If any family member has a diagnosis indicating a genetic disease, an alert is generated for the patient or their relatives. This prompts clinicians to confirm or rule out the possibility of inheritance.

Another significant patent is the "Voice-activated ambulance booking" system. This invention relates to methods and user interfaces that allow non-medical users to book ambulances using voice commands. The system guides the user through a series of questions about the patient's condition, which can be answered by simply observing the patient. Based on the responses, an ambulance is requested, and the system can resolve conflicts if multiple requests are made by considering the user device's vitals.

Career Highlights

Soumen Tapadar is currently employed at Cerner Innovation, Inc., where he continues to develop groundbreaking technologies. His work focuses on enhancing patient care and streamlining emergency response systems.

Collaborations

He collaborates with talented individuals such as Prashant Pagi and Leena Verma, contributing to a dynamic and innovative work environment.

Conclusion

Soumen Tapadar's contributions to healthcare technology and emergency services exemplify the impact of innovation in improving patient outcomes. His patents reflect a commitment to addressing critical health challenges through technology.